Fidia returns to market

Being in deep waters and compelled to the receivership the pharmaceutical company Fidia tries it again, relying on the roped party composed by Prochimica and Efibanca (Bnl Group). Pietro Rastelli is the new president of the company, operating mainly in the osteoarticular, ophthalmic and neuroscience sectors.